Swiss stocks are showing modest gains in mid-day trading on Thursday. The move continues the modest uptick the market has seen in the last few days, stabilizing after the sharp drop experienced on Monday.
Volume is light and lingering concerns about the debt situation in Europe are keeping traders on the sidelines. Economic data from the U.S. will help guide trading during the afternoon.
The benchmark SMI is up 0.07 percent to 6,468.83. The SLI is up 0.19 percent to 1,008.95. The SPI is up 0.11 percent to 5,949.17.
Nobel Biocare is one of the most notable gainers on the day. Shares are up 6.8 percent on positive analyst comments. Morgan Stanley raised its rating to Overweight from Underweight, citing substantive improvement in the dental implant market.
UBS is gaining ground as well. There is a report in the Wall Street Journal that the firm plans to separate its investment bank and incorporate it outside of Switzerland. Shares are up 1.5 percent.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.